Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Peptides-containing-N-substituted-L-amino-acids-for-preventing-beta-strand-association

 Methods for diagnosing early Lyme disease
This invention is based upon the discovery that sera from patients with early Lyme disease contain ...


 Tango 243 polypeptides and uses thereof
The present invention is based, at least in part, on the discovery of cDNA molecules which encode ...


 Dermatophagoides proteins and fragments thereof
What is claimed is: 1. An isolated protein comprising an amino acid sequence selected from the ...


 Tuberculin active proteins and peptides from the cells of tubercle bacilli
What is claimed is: 1. A tuberculin active simple protein from Mycobacterium tuberculosis strain A...


 Therapy for injured muscles
We claim: 1. A method for treating an injured muscle, the method comprising the step of local ...


 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1. PRO1560 A cDNA clone (DNA19902-1669) has been identified that encodes a novel polypeptide ...


 HIV-specific cytotoxic T-cell responses
OF INVENTION The inventors have found that two nanomer peptides, designated CLP-177 (SEQ ID NO:2) ...


 Method of immunomodulatory treatment of insulin dependent diabetes mellitus using mycobacterial cell wall compositions
OF PREFERRED EMBODIMENTS The present invention contemplates a method of immunomodulatory therapy ...


 Susceptibility mutation for breast and ovarian cancer
OF THE PREFERRED EMBODIMENTS The present invention is based on the discovery of a two base pair ...


 Avirulent herpetic viruses useful as tumoricidal agents and vaccines
The present invention provides a herpetic virus selected from the group consisting of neurotrophic ...


 Peptides containing N-substituted L-amino acids for preventing .beta.-strand association

Details
Inventors: Stott, Kelvin;
Assignee: Senexis Limited (Manchester, GB)
Primary Examiner: Weber; Jon
Assistant Examiner: Liu; Samuel Wei
Attorney, Agent or Firm: Jacobson Holman PLLC

Peptide is disclosed which is capable of binding to .beta.-strand in a separate peptide-containing molecule to form .beta.-sheet, wherein said peptide is selectively N.alpha.-substituted in one edge (first) of the .beta.-strand-forming section of said peptide while the other edge (second) in the opposite orientation to the first edge in view of peptide backbone plane remains N.alpha.-unsubstituted. Such the N.alpha.-substituted peptide is capable of preventing association of said peptide with other .beta.-strand (target) but permits interaction of said peptide with target .beta.-strand in separate peptide-containing molecules through the N.alpha.-unsubstituted edge.

DETAILED DESCRIPTION The invention claimed is: 1.
A peptide comprising a peptide, wherein: (a) said peptide comprises a .
beta.
-strand-forming section, said section consisting of four to sixteen consecutive .
alpha.
-L-amino acid residues and encompassing at least 50% of the length of said peptide, none of the .
alpha.
-L-amino acid residues within the .
beta.
-strand-forming section being proline, except at very ends of the .
beta.
-strand-forming section; (b) each of the consecutive .
alpha.
-L-amino acid residues in the .
beta.
-strand-forming section has a side chain; (c) said .
beta.
-strand-forming section forms a .
beta.
-strand having a peptide backbone which takes on the form of an extended ribbon having two edges, a first edge which associates with a target .
beta.
-strand formed by a separate peptide-containing molecule and a second edge, such that the NH and CO components of successive .
alpha.
-L-amino acid residues lie along the first edge and the second edge of the ribbon, the first edge and second edge corresponding to two opposite edges of the plane of the ribbon, and the side chains of the consecutive .
alpha.
-L-amino acid residues being alternatively above or below the plane of the ribbon; (d) at least one of the N.
alpha.
-atoms within the peptide backbone of the .
beta.
-strand is N.
alpha.
-substituted with an N.
alpha.
-substituent, such that one or more N.
alpha.
-substituent lie along only the second edge and sterically hinder the association of the second edge with another .
beta.
-strand; and (e) the first edge remains free of N.
alpha.
-substituents, and is not prevented from associating with the target .
beta.
-strand formed by a separate peptide-containing molecule.
2.
The peptide according to claim 1, wherein, when there are two or more successive N.
alpha.
-substituted amino acid residues, no two successive N.
alpha.
-substituted amino acid residues in the .
beta.
-strand-forming section are separated by more than 3 consecutive N.
alpha.
-unsubstituted amino acid residues.
3.
The peptide according to claim 1 wherein, when there are two or more successive N



Related patents
  Lectins and antiretroviral drugs containing the lectins as active ingredient
OF THE INVENTION The lectins of the present invention are obtained from the plants of the class Dicotyledoneae and have a function for inhibiting the reverse ...
  Activated dendritic cells and methods for their activation
The present invention pertains to a method of activating dendritic cells to enhance antigen presenting capacity. The activated, antigen-presenting dendritic cells of the ...
  Methods and compositions for obtaining mature dendritic cells
OF THE INVENTION This invention relates to methods and compositions useful for promoting the maturation of immature dendritic cells to a mature and stable phenotype as ...
  Nucleic acid encoding a lectin-derived progenitor cell preservation factor
It has now been discovered that these and other objectives can be achieved by the present invention, which provides an isolated nucleic acid comprising a nucleotide ...
  Ligand for vascular endothelial growth factor receptor
We claim: 1. A compound comprising amino acid sequence Glu-Ile-Glu-Trp-Tyr-Ser-Trp-Val-Thr-His-Gly-Met-Tyr (SEQ ID NO:29). 2. A pharmaceutical composition comprising ...
  Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines
What is claimed is: 1. An immunologically active Borrelia burgdorferi protein free of other proteins isolated from Borrelia burgdorferi, which protein comprises SEQ ID NO...
  Immunoliposomes that optimize internalization into target cells
The present invention provides novel immunoliposomes optimized for delivering therapeutic agents to the cytoplasm of a target cell. These immunoliposomes exhibit ...
  Virus-like particles for the induction of autoantibodies
The inventors have discovered compositions and methods of increasing the titers of antibodies to tolerogens (e.g., self antigens and foreign antigens) over those titers ...
  Ferritin analogs
Despite the fact that ferritin is extremely selective in accumulating, storing and dispensing iron in living things, I have discovered that the forgoing objectives can ...
  Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
What is claimed is: 1. A method for the treatment of a tumor in a mammal, comprising the steps of (i) identifying said tumor as being characterized by overexpression of ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved